Index by author
Jordan, John E.
- EDITOR'S CHOICEHealth Policies/Quality Improvement/Evidence-Based NeuroimagingYou have accessState of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney DiseaseKirk M. Welker, David Joyner, Anthony W. Kam, David S. Liebeskind, Amit M. Saindane, Colin Segovis, Noushin Yahyavi-Firouz-Abadi and John E. JordanAmerican Journal of Neuroradiology February 2025, 46 (2) 227-230; DOI: https://doi.org/10.3174/ajnr.A8501
The ASNR Standards and Guidelines Committee reviewed new research evidence on GBCA safety and its relevance to current MRI contrast administration guidelines for patients with CKD. The recommendations for CKD patients are that there is no longer a need to withhold group II GBCAs when medically indicated for diagnosis and that it is not necessary to check renal function for these agents.
Joyce, Julie M.
- Ultra-High-Field MRI/Imaging of Epilepsy/Demyelinating Diseases/Inflammation/InfectionYou have accessQuantitative Susceptibility Mapping in Adults with Persistent Postconcussion Symptoms after Mild Traumatic Brain Injury: An Exploratory StudyTiffany K. Bell, Muhammad Ansari, Julie M. Joyce, Leah J. Mercier, David G. Gobbi, Richard Frayne, Chantel Debert and Ashley D. HarrisAmerican Journal of Neuroradiology February 2025, 46 (2) 435-442; DOI: https://doi.org/10.3174/ajnr.A8454
Joyner, David
- EDITOR'S CHOICEHealth Policies/Quality Improvement/Evidence-Based NeuroimagingYou have accessState of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney DiseaseKirk M. Welker, David Joyner, Anthony W. Kam, David S. Liebeskind, Amit M. Saindane, Colin Segovis, Noushin Yahyavi-Firouz-Abadi and John E. JordanAmerican Journal of Neuroradiology February 2025, 46 (2) 227-230; DOI: https://doi.org/10.3174/ajnr.A8501
The ASNR Standards and Guidelines Committee reviewed new research evidence on GBCA safety and its relevance to current MRI contrast administration guidelines for patients with CKD. The recommendations for CKD patients are that there is no longer a need to withhold group II GBCAs when medically indicated for diagnosis and that it is not necessary to check renal function for these agents.
Juliano, Amy F.
- Head and Neck ImagingYou have accessThe “Outline Sign”: Thin Hyperenhancing Perimeter as an MR Imaging Feature of Meningioma. A Useful Tool in the Temporal Bone Region for Differentiating Meningiomas from Schwannomas and ParagangliomasAnil K. Vasireddi, Katherine L. Reinshagen, Donghoon Shin, Laura V. Romo and Amy F. JulianoAmerican Journal of Neuroradiology February 2025, 46 (2) 349-354; DOI: https://doi.org/10.3174/ajnr.A8452
Kaliaev, Artem
- Head and Neck ImagingYou have accessComparison of Imaging Findings between Granulomatosis with Polyangiitis and Eosinophilic Granulomatosis with Polyangiitis on Sinus CT: Importance of High-Density Opacification of the Paranasal SinusesInseon Ryoo, Serena Poésy, Artem Kaliaev, Karen Buch and Osamu SakaiAmerican Journal of Neuroradiology February 2025, 46 (2) 355-361; DOI: https://doi.org/10.3174/ajnr.A8485
Kam, Anthony W.
- EDITOR'S CHOICEHealth Policies/Quality Improvement/Evidence-Based NeuroimagingYou have accessState of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney DiseaseKirk M. Welker, David Joyner, Anthony W. Kam, David S. Liebeskind, Amit M. Saindane, Colin Segovis, Noushin Yahyavi-Firouz-Abadi and John E. JordanAmerican Journal of Neuroradiology February 2025, 46 (2) 227-230; DOI: https://doi.org/10.3174/ajnr.A8501
The ASNR Standards and Guidelines Committee reviewed new research evidence on GBCA safety and its relevance to current MRI contrast administration guidelines for patients with CKD. The recommendations for CKD patients are that there is no longer a need to withhold group II GBCAs when medically indicated for diagnosis and that it is not necessary to check renal function for these agents.
Kambe, Atsushi
- NeurointerventionYou have accessClinical Outcome of Pipeline Embolization Device with and without Coils to Treat Intracranial Aneurysm: A Systematic Review and Meta-AnalysisIrfan Kesumayadi, Makoto Sakamoto, Tomohiro Hosoya, Atsushi Kambe, Tetsuji Uno, Hiroki Yoshioka and Masamichi KurosakiAmerican Journal of Neuroradiology February 2025, 46 (2) 272-277; DOI: https://doi.org/10.3174/ajnr.A8443
Kapse, Kushal
- Pediatric NeuroimagingYou have accessQuantitative Susceptibility Mapping with Source Separation in Normal Brain Development of NewbornsMinJung Jang, Alexey V. Dimov, Kushal Kapse, Jonathan Murnick, Zachary Grinspan, Alan Wu, Arindam RoyChoudhury, Yi Wang, Pascal Spincemaille, Thanh D. Nguyen, Catherine Limperopoulos and Zungho ZunAmerican Journal of Neuroradiology February 2025, 46 (2) 380-389; DOI: https://doi.org/10.3174/ajnr.A8488
Keser, Zafer
- FELLOWS' JOURNAL CLUBNeurovascular/Stroke ImagingYou have accessAssessment of Attenuation in Pericarotid Fat among Patients with Carotid Plaque and Spontaneous Carotid DissectionMohammed O. Alalfi, Riccardo Cau, Giovanni Maria Argiolas, Roberta Scicolone, Cesare Mantini, Valentina Nardi, John C. Benson, Jasjit S. Suri, Zafer Keser, Amir Lerman, Giuseppe Lanzino, Paolo Siotto and Luca SabaAmerican Journal of Neuroradiology February 2025, 46 (2) 259-264; DOI: https://doi.org/10.3174/ajnr.A8546
This cross-sectional retrospective study assessed the PFD in patients with spontaneous internal carotid artery dissection or carotid atherosclerotic plaque, with and without IPH. The results showed that the average PFDs in patients with SICAD and carotid atherosclerosis plaque with IPH were similar and higher than those in patients with carotid plaque without IPH, suggesting a shared pathologic inflammatory mechanism in these 2 conditions.
Kesumayadi, Irfan
- NeurointerventionYou have accessClinical Outcome of Pipeline Embolization Device with and without Coils to Treat Intracranial Aneurysm: A Systematic Review and Meta-AnalysisIrfan Kesumayadi, Makoto Sakamoto, Tomohiro Hosoya, Atsushi Kambe, Tetsuji Uno, Hiroki Yoshioka and Masamichi KurosakiAmerican Journal of Neuroradiology February 2025, 46 (2) 272-277; DOI: https://doi.org/10.3174/ajnr.A8443
In this issue
